Chemfab Alkalis files FY26 annual report with ₹7.51 crore profit

2 min read     Updated on 17 Aug 2026, 09:14 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Chemfab Alkalis Limited filed its FY26 annual report, showing consolidated revenue of ₹2,885.6 crore and PAT of ₹7.51 crore. The company completed key investments in electrolyser modernisation and OPVC pipe capacity expansion, positioning itself for growth in FY27 as government water infrastructure funding resumes.

powered bylight_fuzz_icon
48526169

*this image is generated using AI for illustrative purposes only.

Chemfab Alkalis Limited has submitted its annual report for the financial year ended March 31, 2026, to the stock exchanges. The filing provides a comprehensive overview of the company’s performance across its chlor-alkali and OPVC pipes segments during a year characterised by soft global caustic soda prices and paused government funding for water infrastructure projects.

Financial Performance in FY26

Consolidated revenue from operations stood at ₹2,885.6 crore in FY26, down from ₹3,220.9 crore in FY25. Profit after tax (PAT) declined to ₹7.51 crore from ₹15.22 crore in the previous year. Operational EBITDA was ₹36.70 crore, reflecting an EBITDA margin of 12.72%.

The chlor-alkali segment reported revenue of ₹1,956.9 crore, broadly stable compared to ₹1,906.4 crore in FY25. The segment recorded an EBIT loss of ₹1.17 crore, a significant improvement from the ₹5.20 crore loss in FY25, driven by recovering realisations in the second half of the year and contributions from the modernised plant.

The OPVC pipes segment saw revenue decline to ₹934.7 crore from ₹1,314.5 crore in FY25, primarily due to the pause in Jal Jeevan Mission funding between October 2024 and March 2026. Despite the revenue drop, the division remained profitable with an EBIT of ₹19.43 crore.

Capacity Expansion and Modernisation

During FY26, Chemfab Alkalis completed major capital projects across both business divisions. In the chlor-alkali segment, the company commissioned a new-generation electrolyser plant in November 2025, replacing the system installed in 1994. This technology modernisation programme, costing ₹56 crore, is expected to materially lower energy consumption and improve automation.

Additionally, a hybrid renewable energy project, structured through a dedicated special purpose vehicle, stands ready and awaits final transmission line clearances. Supply is expected to commence from Q1 FY27, after which renewable sources will meet close to 55% of the company’s energy needs.

In the OPVC pipes segment, Lines 5 and 6 were commissioned during the year, increasing capacity from 14,000 TPA to 20,000 TPA. Line 7 is scheduled to complete the Sri City site at 23,000 TPA in FY27. The company is now approved in 15 states for public water supply schemes, including Bihar and Gujarat added during FY26.

Outlook for FY27

Management expects FY27 to be materially stronger than FY26. The approval of Jal Jeevan Mission 2.0 with an allocation of ₹67,600 crore for FY27 is expected to restore the funding pipeline for rural water infrastructure, with meaningful disbursements anticipated from Q2 FY27. In the chlor-alkali segment, stabilising realisations, efficiencies from the modernised facility, and the commencement of hybrid power supply are expected to drive improved profitability.

Corporate Governance and Dividend

The Board recommended a final dividend of ₹1.25 per equity share, representing a payout rate of 12.50% on the face value of ₹10. The 17th Annual General Meeting is scheduled for September 9, 2026. Key agenda items include the reappointment of Suresh Krishnamurthi Rao as director and the appointment of M/s. M S K C & Associates LLP as statutory auditors for a five-year term.

What the Numbers Show

The divergence between the chlor-alkali and OPVC segments highlights the distinct cyclical drivers affecting each business. While the chlor-alkali segment benefited from cost efficiencies and recovering prices, the OPVC segment faced demand headwinds due to regulatory funding delays. However, the completion of capacity expansions positions the company to capture growth when government funding resumes, particularly given its leadership position in the OPVC market with the widest product range in India.

Historical Stock Returns for Chemfab Alkalis

1 Day5 Days1 Month6 Months1 Year5 Years
-2.35%-0.56%-1.06%-3.45%-46.31%+127.99%

How will the commencement of the hybrid renewable energy supply in Q1 FY27 impact Chemfab Alkalis' long-term cost structure and margin stability in the chlor-alkali segment?

Given the ₹67,600 crore allocation for Jal Jeevan Mission 2.0, what is the expected timeline for order book normalization in the OPVC pipes segment following the funding pause?

Will the newly commissioned 20,000 TPA capacity in the OPVC segment be sufficient to meet anticipated demand spikes, or does Chemfab need further expansion to maintain its market leadership?

Chemfab Alkalis net profit surges 124% in Q1FY27 on tax credit

3 min read     Updated on 01 Aug 2026, 08:52 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Chemfab Alkalis delivered a consolidated net profit of ₹573.04 million in Q1FY27, up 124% YoY, largely due to a ₹380.27 million deferred tax credit from opting for a lower tax rate. Despite this, revenue fell 20.1% to ₹7,315.98 million, driven by a sharp decline in the PVC-O Pipes segment, while the Chemicals segment showed resilience.

powered bylight_fuzz_icon
46889689

*this image is generated using AI for illustrative purposes only.

Chemfab Alkalis reported a consolidated net profit of ₹573.04 million for the quarter ended June 30, 2026, marking a 124% increase from ₹254.76 million in the corresponding period last year. The Chennai-based chemical manufacturer attributed this surge primarily to a significant deferred tax credit of ₹380.27 million, which offset operational headwinds including a 20.1% year-on-year revenue decline. This accounting adjustment significantly boosted headline earnings, masking underlying pressure in the pre-tax numbers where profit before tax fell 52.7% to ₹222.37 million.

The Board of Directors approved the unaudited standalone and consolidated financial results on July 29, 2026, following review by the Audit Committee. The results were supported by a limited review report from current statutory auditors Deloitte Haskins & Sells LLP. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III thereof and SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, the company published the results in Business Standard and Makkal Kural on July 31, 2026. Additionally, the company appointed M/s. M S K A & Associates LLP as its new statutory auditor for a five-year term, effective from the conclusion of the ensuing Annual General Meeting.

Financial Performance Overview

Despite the revenue contraction, Chemfab Alkalis delivered strong bottom-line growth due to non-operating factors. The total tax expense for the quarter was a credit of ₹350.67 million, contrasting with an expense of ₹215.22 million in the prior year period. This reversal was largely due to the re-measurement of Deferred Tax Liabilities after the company exercised the option for a lower tax rate under Section 200 of the Income Tax Act 2025 (erstwhile Section 115BAA).

Metric Q1FY27 Q1FY26 Change
Revenue from Operations ₹7,315.98 M ₹9,154.09 M -20.1%
Profit Before Tax ₹222.37 M ₹469.98 M -52.7%
Net Profit After Tax ₹573.04 M ₹254.76 M +124.9%
Earnings Per Share (Basic) ₹3.99 ₹1.77 +125.4%

Segmental Analysis

The company operates through two reportable segments: Chemicals and Related Products, and PVC-O Pipes. The Chemicals segment contributed ₹6,741.01 million to revenue, up from ₹5,283.89 million in Q1FY26, showing resilience in this core business area. In contrast, the PVC-O Pipes segment saw a sharp decline in revenue to ₹574.97 million from ₹3,870.20 million year-on-year.

Segment profitability mirrored this trend. The Chemicals segment reported a result before tax of ₹292.03 million, improving from a loss of ₹372.49 million in the previous year. Conversely, the PVC-O Pipes segment incurred a loss before tax of ₹57.23 million, compared to a profit of ₹863.16 million in Q1FY26. This divergence highlights the shifting dynamics within the group’s portfolio, with the chemicals business offsetting weaknesses in the piping division.

Operational Updates and Outlook

Management highlighted that ECU realisations in the Chlor-Alkali business improved sequentially from ₹39,100 per MT to ₹39,600 per MT during the quarter. A 10 MW Captive Hybrid Power supply commenced on May 25, 2026, expected to deliver long-term cost savings. During the quarter, the company invested ₹1,491 million towards sourcing power from the hybrid power plant under a power purchase agreement.

In the OPVC segment, demand remained impacted by the absence of fund flows under the Jal Jeevan Mission, with improvements expected from Q2FY27 onwards. The Bureau of Indian Standards (BIS) recently approved OPVC pipes for sewage applications, opening new market avenues. Direct manufacturing expenses included job work expenses of ₹364.47 million related to the production of aluminium chloride.

What the Numbers Show

The stark contrast between the decline in Profit Before Tax (-52.7%) and the surge in Net Profit (+124.9%) underscores the dominance of tax adjustments in driving the headline earnings for Q1FY27. While the operational performance improved in the Chemicals segment, the overall pre-tax profit fell significantly due to the collapse in the PVC-O Pipes segment’s contribution. Investors should note that the reported net profit growth is largely attributable to the one-time tax credit rather than sustained operational leverage or revenue expansion.

Historical Stock Returns for Chemfab Alkalis

1 Day5 Days1 Month6 Months1 Year5 Years
-2.35%-0.56%-1.06%-3.45%-46.31%+127.99%

Will the ₹380 million deferred tax credit be a recurring benefit in future quarters, or is it a one-time adjustment that will normalize earnings?

How significant will the revenue recovery from the Jal Jeevan Mission fund flows be for the PVC-O Pipes segment starting Q2FY27?

Can the new BIS approval for OPVC pipes in sewage applications sufficiently offset the current demand slump in the piping division?

More News on Chemfab Alkalis

1 Year Returns:-46.31%